You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Neomycin And Polymyxin B Sulfates And Bacitracin Zinc patents expire, and what generic alternatives are available?

Neomycin And Polymyxin B Sulfates And Bacitracin Zinc is a drug marketed by Bausch And Lomb, Padagis Us, and Sciegen Pharms Inc. and is included in three NDAs.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC is bacitracin zinc; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the bacitracin zinc; neomycin sulfate; polymyxin b sulfate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
  • What are the global sales for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
  • What is Average Wholesale Price for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?
Summary for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
US Patents:0
Applicants:3
NDAs:3
Finished Product Suppliers / Packagers: 2
What excipients (inactive ingredients) are in NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC?NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC excipients list
DailyMed Link:NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC at DailyMed
Drug patent expirations by year for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC
Pharmacology for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

US Patents and Regulatory Information for NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 064064-001 Oct 30, 1995 AT RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 060764-002 Approved Prior to Jan 1, 1982 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sciegen Pharms Inc NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC bacitracin zinc; neomycin sulfate; polymyxin b sulfate OINTMENT;OPHTHALMIC 065088-001 Feb 6, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.